Sign in
8-K

Current Report

Spyre Therapeutics, Inc. Filed Acc 0001564590-19-007016

Executive or director change

  • Item 5.02 Departure or appointment of directors or officers

From the SEC's structured data for this filing

Loading agle-8k_20190308.htm…